Not Signed In -
Alfuzosin |
alfuzosin hydrochloride; UroXatral |
Alfuzosin Systematic (IUPAC) name N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide Identifiers CAS number 81403-80-7 ATC code G04CA01 PubChem 2092 DrugBank APRD00490 Chemical data Formula C19H27N5O4 Mol. weight 389.449 g/mol Pharmacokinetic data Bioavailability 49% Protein binding 82%-90% Metabolism Hepatic (CYP3A4-mediated) Half life 10 hours Excretion Fecal (69%) and renal (24%) Therapeutic con ...
Wikipedia - [full article]
Alfuzosin Clinical Trials
- Trial to Compare Alfuzosin versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
ClinicalTrials.gov Identifier: NCT00103402 - Active, not recruiting
Prostatitis
- Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH
ClinicalTrials.gov Identifier: NCT00347061 - Active, not recruiting
Benign Prostatic Hyperplasia
- Use of Alfuzosin in Stone Treatment With ESWL
ClinicalTrials.gov Identifier: NCT00388271 - Recruiting
Urinary Calculi
- Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia
ClinicalTrials.gov Identifier: NCT00399464 - Active, not recruiting
Prostatic Hyperplasia
- SAMBA-Thailand: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
ClinicalTrials.gov Identifier: NCT00401661 - Active, not recruiting
Prostatic Hyperplasia
- SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
ClinicalTrials.gov Identifier: NCT00486785 - Active, not recruiting
Prostatic Hyperplasia
- Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy
ClinicalTrials.gov Identifier: NCT00409227 - Recruiting
Urolithiasis; Nephrolithiasis; Ureterolithiasis
- Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology
ClinicalTrials.gov Identifier: NCT00576823 - Recruiting
Hydronephrosis; Neurogenic Bladder
- A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones
ClinicalTrials.gov Identifier: NCT00583258 - Recruiting
Kidney Stones
- Alfuzosin for Treating Acute Urinary Retention
ClinicalTrials.gov Identifier: NCT00336921 - Active, not recruiting
Acute Urinary Retention
- Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
ClinicalTrials.gov Identifier: NCT00177086 - Recruiting
Kidney Calculi; Ureteral Calculi; Colic
- Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction
ClinicalTrials.gov Identifier: NCT00549939 - Recruiting
Neurogenic Urinary Bladder
- Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort
ClinicalTrials.gov Identifier: NCT00467467 - Recruiting
Ureteral Stent Discomfort
- ALF-ONE : ALFuzosin ONcE Daily
ClinicalTrials.gov Identifier: NCT00280605 - Completed
Prostatic Hyperplasia
- Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study
ClinicalTrials.gov Identifier: NCT00575913 - Completed
Prostatic Diseases
- Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy
ClinicalTrials.gov Identifier: NCT00542165 - Completed
BPH/LUTS/Sexual Functions
- ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH
ClinicalTrials.gov Identifier: NCT00290030 - Completed
Prostatic Hyperplasia; Acute Urinary Retention
- Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia
ClinicalTrials.gov Identifier: NCT00409357 - Completed
Benign Prostatic Hyperplasia
- The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score
ClinicalTrials.gov Identifier: NCT00540891 - Completed
Benign Prostatic Hyperplasia
- ALF-STONE: Alfuzosin in Uretheric Stones
ClinicalTrials.gov Identifier: NCT00454402 - Terminated
Prostatic Hyperplasia
- Clinical Trial in Males with BPH (Enlarged Prostate)
ClinicalTrials.gov Identifier: NCT00029822 - Completed
Urinary Retention; Prostatic Hyperplasia; Benign Prostatic Hypertrophy
- Alfuzosin Versus Placebo in Acute Urinary Retention
ClinicalTrials.gov Identifier: NCT00453908 - Terminated
Urinary Retention
- Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
ClinicalTrials.gov Identifier: NCT00563654 - Terminated
Prostatic Hyperplasia; Urinary Retention; Acute Disease
- MIST: A Comparison of Transurethral Needle Ablation (TUNA), Transurethral Microwave Therapy (TUMT), and Medical Therapy for Benign Prostatic Hyperplasia
ClinicalTrials.gov Identifier: NCT00064649 - Terminated
Benign Prostatic Hyperplasia
email this page
print this page
bookmark this page
feedback on this page
